{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:19:40Z","timestamp":1789903180148,"version":"4.0.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.biopha.2017.01.118","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T18:17:28Z","timestamp":1485800248000},"page":"755-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells"],"prefix":"10.1016","volume":"87","author":[{"given":"Francesco","family":"Petrella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cocc\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Masia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela Omodeo","family":"Sal\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Alessandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pentimalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna T.","family":"Brini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.01.118_bib0005","first-page":"233","article-title":"Pleural tumors","volume":"1","author":"McNamee","year":"2014"},{"issue":"1","key":"10.1016\/j.biopha.2017.01.118_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/sonc.2002.30237","article-title":"Ths epidemiology of mesothelioma","volume":"29","author":"Britton","year":"2002","journal-title":"Semin. Oncol."},{"issue":"August","key":"10.1016\/j.biopha.2017.01.118_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.critrevonc.2016.05.004","article-title":"The third italian consensus conference for malignant pleural mesothelioma: state of the art and recommendations","volume":"104","author":"Novello","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2017.01.118_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00685684","article-title":"Chemotherapy in malignant mesothelioma: a review","volume":"28","author":"Krauf-Hansen","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2017.01.118_bib0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bjc.1996.465","article-title":"Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group","volume":"74","author":"van Meerbeeck","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"March (6)","key":"10.1016\/j.biopha.2017.01.118_bib0030","article-title":"Mesenchymal stem cells as delivery vectors for anti-tumor therapy","volume":"2","author":"Li","year":"2015","journal-title":"Stem Cell Investig."},{"issue":"12","key":"10.1016\/j.biopha.2017.01.118_bib0035","doi-asserted-by":"crossref","first-page":"e28321","DOI":"10.1371\/journal.pone.0028321","article-title":"Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy","volume":"6","author":"Pessina","year":"2011","journal-title":"PLoS One"},{"issue":"January (1)","key":"10.1016\/j.biopha.2017.01.118_bib0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/rcr2.145","article-title":"Repetitive responses to nanoparticle albumin-bound paclitaxel and carboplatin in malignant pleural mesothelioma","volume":"4","author":"Kanai","year":"2016","journal-title":"Respirol. Case Rep."},{"key":"10.1016\/j.biopha.2017.01.118_bib0045","unstructured":"NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996."},{"key":"10.1016\/j.biopha.2017.01.118_bib0050","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.87.10.4012","article-title":"A cystic fibrosis pancreatic adenocarcinoma cell line","volume":"87","author":"Schoumacher","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2017.01.118_bib0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biopha.2017.01.118_bib0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mossman","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2017.01.118_bib0065","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"issue":"August (31)","key":"10.1016\/j.biopha.2017.01.118_bib0070","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.3748\/wjg.v22.i31.7080","article-title":"Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma","volume":"22","author":"Hsueh","year":"2016","journal-title":"World J. Gastroenterol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217302111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217302111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:50:15Z","timestamp":1785336615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217302111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":14,"alternative-id":["S0753332217302111"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.118","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}